Altis Biosystems, Inc.

Altis Biosystems, Inc.

Our RepliGut® Systems recreate the human intestinal epithelium in vitro enabling researchers to characterize intestinal toxicity risk earlier, leading to better prediction of safety profiles. RepliGut® Systems derive from human primary stem cells capable of differentiating into key cell-types in the gut epithelium for testing off-target damage to the intestine. Our ethically sourced biobank of stem cells consists of many donors and regions and is available to set up in house or as a service

Biotechnology, ADME (Absorption/Distribution/Metabolism/Excretion), Cells/Tissue, CRO—Contract Research Organization, In Vitro, Metabolism Studies, Preclinical, High Throughput Test Systems, Modeling, Research/Testing